Successful rechallenge with cetuximab after progression with nivolumab for recurrent cervical lymph node metastasis from carcinoma of the tongue

We can infer that the immunostimulatory effect of nivolumab and reactivation of cetuximab enhance the antitumor effect of the therapy. We can infer that the immunostimulatory effect of nivolumab and reactivation of cetuximab enhance the antitumor effect of the therapy.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical Case Reports 2021-07, Vol.9 (7), p.e04464-n/a
Hauptverfasser:	Asada, Yasuyuki, Teramura, Chitoshi, Wada, Takuma, Machida, Yoshisato, Koshinuma, Shinya, Yamamoto, Gaku
Format:	Artikel
Sprache:	eng
Schlagworte:	B cells Cancer Cancer surgery Cancer therapies carcinoma of the tongue Case Report Case Reports cetuximab Chemotherapy Complications and side effects Development and progression Diseases Drug dosages Drug therapy General anesthesia Head & neck cancer Lymphatic system Magnetic resonance imaging Metastasis nivolumab rechallenge Relapse Squamous cell carcinoma Tomography Tongue
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	We can infer that the immunostimulatory effect of nivolumab and reactivation of cetuximab enhance the antitumor effect of the therapy. We can infer that the immunostimulatory effect of nivolumab and reactivation of cetuximab enhance the antitumor effect of the therapy.
ISSN:	2050-0904 2050-0904
DOI:	10.1002/ccr3.4464